Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success

SIMPLE SUMMARY: Chimeric antigen receptor (CAR) T-cells are powerful therapeutic tools that have revolutionized the treatment of several hematological malignancies. However, their therapeutic application in acute myeloid leukemia (AML) remains challenging. In this review, the authors aimed to dissec...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelozzi, Ilaria M., Kirtsios, Efstratios, Giustacchini, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201025/
https://www.ncbi.nlm.nih.gov/pubmed/34198742
http://dx.doi.org/10.3390/cancers13112816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201025/
https://www.ncbi.nlm.nih.gov/pubmed/34198742
http://dx.doi.org/10.3390/cancers13112816

Ejemplares similares